The combination of rifampicin and other antituberculous agents in chronic murine tuberculosis.
D000818:Animals; D002452:Cell Count; D002908:Chronic Disease; D004195:Disease Models, Animal; D004357:Drug Synergism; D004977:Ethambutol / Q000627:therapeutic use*; D005000:Ethionamide / Q000627:therapeutic use*; D007538:Isoniazid / Q000097:blood / Q000627:therapeutic use*; D008168:Lung / Q000382:microbiology; D051379:Mice; D010919:Placebos; D012293:Rifampin / Q000097:blood / Q000627:therapeutic use*; D013307:Streptomycin / Q000097:blood / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy*
D010919:Placebos; D004977:Ethambutol; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin